| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |